QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
NYSE:WST

West Pharmaceutical Services - WST Stock Forecast, Price & News

$335.03
+3.07 (+0.92%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$333.26
$337.13
50-Day Range
$245.93
$336.41
52-Week Range
$206.19
$424.00
Volume
456,399 shs
Average Volume
627,776 shs
Market Capitalization
$24.88 billion
P/E Ratio
43.40
Dividend Yield
0.23%
Price Target
$291.25

West Pharmaceutical Services MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
13.1% Downside
$291.25 Price Target
Short Interest
Healthy
2.09% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.53
Upright™ Environmental Score
News Sentiment
0.56mentions of West Pharmaceutical Services in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$14.18 M Sold Last Quarter
Proj. Earnings Growth
14.11%
From $7.37 to $8.41 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.55 out of 5 stars

Medical Sector

114th out of 983 stocks

Surgical & Medical Instruments Industry

12th out of 100 stocks


WST stock logo

About West Pharmaceutical Services (NYSE:WST) Stock

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

WST Stock News Headlines

Healthcare Stocks With at Least 30 Years of Dividend Increases (WST)
Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
West Announces Second-Quarter 2023 Dividend
MMSI vs. WST: Which Stock Is the Better Value Option?
See More Headlines
Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

WST Company Calendar

Ex-Dividend for 2/1 Dividend
1/24/2023
Dividend Payable
2/01/2023
Last Earnings
2/16/2023
Today
3/21/2023
Ex-Dividend for 5/3 Dividend
4/25/2023
Next Earnings (Estimated)
4/27/2023
Dividend Payable
5/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
CUSIP
95530610
Employees
13,550
Year Founded
1923

Price Target and Rating

Average Stock Price Forecast
$291.25
High Stock Price Forecast
$375.00
Low Stock Price Forecast
$250.00
Forecasted Upside/Downside
-13.4%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$585.90 million
Pretax Margin
23.55%

Debt

Sales & Book Value

Annual Sales
$2.89 billion
Cash Flow
$10.60 per share
Book Value
$36.22 per share

Miscellaneous

Free Float
73,824,000
Market Cap
$24.97 billion
Optionable
Optionable
Beta
1.08

Social Links


Key Executives

  • Eric Mark Green
    President, Chief Executive Officer & Director
  • Bernard J. Birkett
    Senior VP, Chief Financial & Operations Officer
  • Silji AbrahamSilji Abraham
    Chief Technology Officer & Senior Vice President
  • Annette F. FavoriteAnnette F. Favorite
    Chief Human Resources Officer & Senior VP
  • Kimberly Banks MacKay
    Secretary, General Counsel & Senior Vice President













WST Stock - Frequently Asked Questions

Should I buy or sell West Pharmaceutical Services stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" WST shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WST, but not buy additional shares or sell existing shares.
View WST analyst ratings
or view top-rated stocks.

What is West Pharmaceutical Services' stock price forecast for 2023?

4 Wall Street research analysts have issued 1-year price objectives for West Pharmaceutical Services' shares. Their WST share price forecasts range from $250.00 to $375.00. On average, they anticipate the company's stock price to reach $291.25 in the next year. This suggests that the stock has a possible downside of 13.1%.
View analysts price targets for WST
or view top-rated stocks among Wall Street analysts.

How have WST shares performed in 2023?

West Pharmaceutical Services' stock was trading at $235.35 on January 1st, 2023. Since then, WST shares have increased by 42.4% and is now trading at $335.03.
View the best growth stocks for 2023 here
.

Are investors shorting West Pharmaceutical Services?

West Pharmaceutical Services saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 1,670,000 shares, an increase of 24.6% from the January 31st total of 1,340,000 shares. Based on an average daily volume of 629,800 shares, the short-interest ratio is presently 2.7 days. Currently, 2.3% of the company's shares are short sold.
View West Pharmaceutical Services' Short Interest
.

When is West Pharmaceutical Services' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our WST earnings forecast
.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) posted its earnings results on Thursday, February, 16th. The medical instruments supplier reported $1.77 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.38. The medical instruments supplier had revenue of $708.70 million for the quarter, compared to the consensus estimate of $657.16 million. West Pharmaceutical Services had a net margin of 20.30% and a trailing twelve-month return on equity of 26.24%. West Pharmaceutical Services's revenue was down 3.0% compared to the same quarter last year. During the same quarter last year, the company earned $2.04 earnings per share.
Read the conference call transcript
.

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Friday, March 3rd. Stockholders of record on Wednesday, April 26th will be given a dividend of $0.19 per share on Wednesday, May 3rd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.23%. The ex-dividend date of this dividend is Tuesday, April 25th.
Read our dividend analysis for WST
.

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services (NYSE:WST) pays an annual dividend of $0.76 per share and currently has a dividend yield of 0.23%. The company has been increasing its dividend for 30 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 9.84%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, WST will have a dividend payout ratio of 9.04% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WST.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services issued an update on its FY 2023 earnings guidance on Monday, February, 20th. The company provided earnings per share (EPS) guidance of $7.25-$7.40 for the period, compared to the consensus EPS estimate of $7.27. The company issued revenue guidance of $2.94 billion-$2.96 billion, compared to the consensus revenue estimate of $2.87 billion.

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services Chief Executive Officer Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among the company's employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Franklin Resources Inc. (3.34%), Price T Rowe Associates Inc. MD (3.11%), T. Rowe Price Investment Management Inc. (2.32%), Geode Capital Management LLC (2.04%), Brown Advisory Inc. (1.64%) and Durable Capital Partners LP (1.50%). Insiders that own company stock include Annette F Favorite, David A Montecalvo, Eric Mark Green, George Lloyd Miller, Patrick J Zenner, Quintin J Lai and Silji Abraham.
View institutional ownership trends
.

How do I buy shares of West Pharmaceutical Services?

Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $335.03.

How much money does West Pharmaceutical Services make?

West Pharmaceutical Services (NYSE:WST) has a market capitalization of $24.88 billion and generates $2.89 billion in revenue each year. The medical instruments supplier earns $585.90 million in net income (profit) each year or $7.72 on an earnings per share basis.

How many employees does West Pharmaceutical Services have?

The company employs 13,550 workers across the globe.

Does West Pharmaceutical Services have any subsidiaries?
The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..
Read More
How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The official website for the company is www.westpharma.com. The medical instruments supplier can be reached via phone at (610) 594-2900, via email at quintin.lai@westpharma.com, or via fax at 800-345-9800.

This page (NYSE:WST) was last updated on 3/21/2023 by MarketBeat.com Staff